Back to CELG-RI
Ikarian Capital, LLC → CELG-RI
Ikarian Capital, LLC CELG-RI Position History
Bristol-Myers Squibb Company Ce • Healthcare
Quarters held
3
Latest value
$61.9M
Q3 2026
Peak value
$61.9M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $30.3M |
| Q2 2026 | $2.4M |
| Q3 2026 | $61.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $61.9M | 992.5K | — | — |
| Q2 2026 | $2.4M | 42.5K | — | — |
| Q1 2026 | $30.3M | 500.0K | — | — |